Peripheral T-cell Lymphoma

• CLINICAL_TRIALS research · 2017-02-13
  Clinical Trial Update: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma [NA]

  This clinical trial update describes evaluating liver SUVmax-based criteria on 18F-FDG PET/CT to predict prognosis in patients with Peripher…

• CLINICAL_TRIALS research · 2016-12-08
  Clinical Trial Update: Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating chidamide with CHOEP chemotherapy and upfront autologous stem cell transplant in untreated peripheral …

• CLINICAL_TRIALS research · 2016-10-26
  Clinical Trial Update: Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma [Phase 2]

  A Phase 2 clinical trial update evaluating chidamide for refractory or relapsed peripheral T cell lymphoma.

• CLINICAL_TRIALS research · 2015-08-11
  Clinical Trial Update: Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study [Phase 2]

  This document reports a Phase II clinical trial of Endostar for peripheral T-cell lymphoma sponsored by Nanjing NingQi Medicine Science and …

• CLINICAL_TRIALS research · 2013-08-26
  Clinical Trial Update: Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma [Phase 1]

  Phase 1 trial of alemtuzumab combined with chemotherapy for peripheral T-cell lymphoma (stages I–IV); current status is unknown.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2012-05-07
  Clinical Trial Update: Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP [Phase 3]

  A Phase 3 clinical trial evaluating adding alemtuzumab to dose-dense CHOP for peripheral T-cell lymphomas, including angioimmunoblastic T-ce…

• CLINICAL_TRIALS research · 2011-11-11
  Clinical Trial Update: Clinical Usefulness and Prognostic Significance of Interim 18F-FDG PET/CT for the Treatment of Peripheral T Cell Lymphomas

  This clinical trial update assesses the usefulness and prognostic value of interim 18F-FDG PET/CT imaging in the treatment of peripheral T-c…

• CLINICAL_TRIALS research · 2010-09-15
  Clinical Trial Update: Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL) [Phase 2]

  A Phase 2 clinical trial evaluating the oral Fludarabine, Adriamycin (doxorubicin), and Dexamethasone (FAD) regimen for newly diagnosed Peri…